NanoMetalene
-
Spine
SeaSpine Announces 25,000th NanoMetalene® Implantation
CARLSBAD, Calif., Dec. 18, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Biologics
SeaSpine Announces 20,000th NanoMetalene® Implantation
CARLSBAD, Calif., July 26, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Spine
SeaSpine® Announces Full Commercial Launch of Vu a∙POD™ Prime NanoMetalene® System
CARLSBAD, Calif., Jan. 31, 2017 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical…
Read More » -
Spine
SeaSpine Introduces Hollywood™ VI NanoMetalene® Interbody Device
CARLSBAD, Calif., June 15, 2016 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions…
Read More » -
Spine
SeaSpine Launches Ventura(TM) NanoMetalene(R) Interbody Device
VISTA, Calif., Aug. 10, 2015 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for…
Read More »